NCT07677995Enrolling by invitation
Free Fatty Acid Effects In Type 2 Diabetes
Repositioning Omega-3 Fatty Acids For Treatment Of Glycaemia And Cardiometabolic Disease
Source: ClinicalTrials.gov · Last updated 1 Sept 2026
Brief summary (registry, in English)
Omega-3 fatty acids are natural fats found in foods such as oily fish and flaxseed. Omega-3 fatty acids have been found to have positive effects on cardiovascular health, but there is less evidence on if they can help manage blood glucose in individuals with both cardiovascular disease and type 2 diabetes. This study will investigate whether the beneficial effects found in omega-3 fatty acids such as lowered blood glucose and reduced inflammation - both of which are important for managing type 2 diabetes and cardiovascular disease, can be beneficial for individuals with type 2 diabetes. As omega-3 fatty acids are already found naturally in food, and are already available as supplements, they could be a safe option to help manage these diseases. The aim of this study is to investigate if omega-3 fatty acids can slow down the progression of type 2 diabetes and reduce the risk of cardiovascular disease in individuals with type 2 diabetes.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 27 May 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- University of Ulster
- Diseases
- Type 2 diabetes
- NCT number
- NCT07677995
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Sept 2026 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Type 2 diabetics or prediabetics who are on an anti-diabetic medication (with the exception of metformin)
- Undergone recent major surgery or planned surgery during the study period
Other illness
- Those who have severe or unstable cardiovascular disease
- Have an active infection
Other
- Have implanted devices (such as pacemakers or defibrillators)
- Are involved in any other type of weight loss study/intervention
- Are pregnant/breastfeeding.
Who the study is looking for
- Individuals who are over 18 years of age with a BMI between 25-50 kg/m2, and who have been diagnosed with T2DM (\>7.0 mmol/l fasting glucose) or pre-diabetes (impaired glucose tolerant 5.0-6.9mmol/l) and are either on no medication, are diet controlled or taking metformin. Participants may also have a history of cardiovascular disease.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| School of Biomedical Sciences Coordinator of this site? Confirm its status | Coleraine | United Kingdom | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.